PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV
March 05, 2024 08:00 ET
|
PetVivo Holdings, Inc.
PetVivo Dual Lists on Upstream's Global Securities Trading App MINNEAPOLIS, MN, March 05, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging...
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California
February 29, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 29, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PetVivo Holdings, Inc. Approved to Dual List on Upstream
February 27, 2024 08:00 ET
|
PetVivo Holdings, Inc.
Trading to begin on March 5, 2024 under “PETV”, all shareholders to receive commemorative NFT MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW)...
Europe Pen Needles Market Forecast Report to 2030, Featuring Embecta, Novo Nordisk, Ypsomed, B.Braun Melsungen, Terumo, Nipro, Owen Mumford, Arkray, UltiMed and Allison Medical
February 21, 2024 10:04 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Europe Pen Needles Market Size, Share & Industry Trends Analysis Report By Type, By Setting, By Application, By Length (8mm, 6mm, 5mm, 10mm, 12mm,...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
February 13, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Feb. 13, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Third Quarter of Fiscal 2024 Financial Results
February 12, 2024 16:00 ET
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the...
Global Joint Pain Injections Market Trends and Analysis to 2028: AI & Data Analytics Enhancing Personalized Care, Driving the Market to $1.47 Billion
February 09, 2024 10:15 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Disposable Syringes Market Forecasted at $20.32 Billion by 2028, Driven by the Increasing Demand for Safe Injection Practices
February 08, 2024 09:41 ET
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Disposable Syringes Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
February 07, 2024 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 06, 2024 12:37 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...